The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Multiparameter flow cytometric analysis of TIM-3 (CD366) expression on human peripheral blood cells. Human whole blood was stained with PE Mouse Anti-Human CD56 antibody (Cat. No. 555516/561903) and either BD Horizon™ BB515 Mouse IgG1 κ Isotype Control (Cat. No. 564416) or BD Horizon BB515 Mouse Anti-Human TIM-3 (CD366) antibody (Cat. No. 565568/565569). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Left Plots: The two-parameter flow cytometric contour plots show the correlated expression patterns of TIM-3 (CD366) expression (or Ig Isotype control staining) versus side scattered light-signals (SSC-A) distinguishing monocyte (intermediate SSC-A) and lymphocyte (low SCC-A) populations.
Right Plots: The two-color flow cytometric contour plots show the correlated expression of CD56 versus TIM-3 (CD366) [or Ig Isotype control staining]. Gated events with the forward and side-light scattering characteristics of viable lymphocytes are displayed.
Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multiparameter flow cytometric analysis of TIM-3 (CD366) expression on human peripheral blood cells. Human whole blood was stained with PE Mouse Anti-Human CD56 antibody (Cat. No. 555516/561903) and either BD Horizon™ BB515 Mouse IgG1 κ Isotype Control (Cat. No. 564416) or BD Horizon BB515 Mouse Anti-Human TIM-3 (CD366) antibody (Cat. No. 565568/565569). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Left Plots: The two-parameter flow cytometric contour plots show the correlated expression patterns of TIM-3 (CD366) expression (or Ig Isotype control staining) versus side scattered light-signals (SSC-A) distinguishing monocyte (intermediate SSC-A) and lymphocyte (low SCC-A) populations.
Right Plots: The two-color flow cytometric contour plots show the correlated expression of CD56 versus TIM-3 (CD366) [or Ig Isotype control staining]. Gated events with the forward and side-light scattering characteristics of viable lymphocytes are displayed.
Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multiparameter flow cytometric analysis of TIM-3 (CD366) expression on human peripheral blood cells. Human whole blood was stained with PE Mouse Anti-Human CD56 antibody (Cat. No. 555516/561903) and either BD Horizon™ BB515 Mouse IgG1 κ Isotype Control (Cat. No. 564416) or BD Horizon BB515 Mouse Anti-Human TIM-3 (CD366) antibody (Cat. No. 565568/565569). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Left Plots: The two-parameter flow cytometric contour plots show the correlated expression patterns of TIM-3 (CD366) expression (or Ig Isotype control staining) versus side scattered light-signals (SSC-A) distinguishing monocyte (intermediate SSC-A) and lymphocyte (low SCC-A) populations.
Right Plots: The two-color flow cytometric contour plots show the correlated expression of CD56 versus TIM-3 (CD366) [or Ig Isotype control staining]. Gated events with the forward and side-light scattering characteristics of viable lymphocytes are displayed.
Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD™ CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and CompBead to ensure that BD Comp beads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
For optimal results, it is recommended to perform 2 washes after staining with antibodies. Cells may be prepared, stained with antibodies and washed twice with wash buffer per established protocols for immunofluorescence staining, prior to acquisition on a flow cytometer. Performing fewer than the recommended wash steps may lead to increased spread of the negative population.
The 7D3 monoclonal antibody specifically binds to T cell immunoglobulin mucin 3 (TIM-3) which is also known as, CD366, or T-cell immunoglobulin and mucin domain-containing protein 3 (TIMD-3/TIMD3). CD366 is encoded by the HAVCR2 gene (Hepatitis A virus cellular receptor 2). CD366 is a type I transmembrane glycoprotein and belongs to the human TIM family (along with TIM-1 and TIM-4) within the immunoglobulin superfamily. CD366 is expressed on Th1, Tc1, Th17, Treg, NK T, and NK cells. CD366 is also expressed on dendritic cells, mast cells, monocytes, and macrophages. It is not expressed by Th2 and B cells. CD366 helps maintain peripheral immune tolerance and homeostasis. CD366 regulates macrophage activation and is a negative regulator of Th1 cell function. Crosslinking of cell surface CD366 by binding to Galectin-9 and/or phosphatidylserine appears to play an important role in either positively or negatively regulating leucocyte functions, such as cytokine production or the phagocytosis of apoptotic cells. CD366 may also be useful as an AML stem cell surface marker because it appears to be more highly expressed by AML leukemia stem cells than by normal bone marrow hematopoietic stem cells.
The antibody was conjugated to BD Horizon BB515 which is part of the BD Horizon Brilliant™ Blue family of dyes. With an Ex Max near 490 nm and an Em Max near 515 nm, BD Horizon BB515 can be excited by the blue laser (488 nm) laser and detected with a 530/30 nm filter. This dye has been exclusively developed by BD Biosciences and is up to seven times brighter than FITC with less spillover into the PE channel. Due to similar excitation and emission properties, BB515, FITC, and Alexa Fluor® 488 cannot be used simultaneously. It is not recommended to use BB515 in cocktails that include Streptavidin conjugates as it may cause high background.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.